|
US4000259A
(en)
|
1975-06-16 |
1976-12-28 |
American Home Products Corporation |
Cyclic dodecapeptide analogs of somatostatin and intermediates
|
|
US4438270A
(en)
|
1977-07-11 |
1984-03-20 |
Merrell Toraude Et Compagnie |
α-Halomethyl derivatives of α-amino acids
|
|
US4191754A
(en)
|
1979-02-28 |
1980-03-04 |
Merck & Co., Inc. |
Bicyclic somatostatin analogs
|
|
US4270537A
(en)
|
1979-11-19 |
1981-06-02 |
Romaine Richard A |
Automatic hypodermic syringe
|
|
AU550730B2
(en)
|
1982-03-09 |
1986-04-10 |
Commonwealth Of Australia, The |
Automated metal detection
|
|
US4596556A
(en)
|
1985-03-25 |
1986-06-24 |
Bioject, Inc. |
Hypodermic injection apparatus
|
|
US4683195A
(en)
|
1986-01-30 |
1987-07-28 |
Cetus Corporation |
Process for amplifying, detecting, and/or-cloning nucleic acid sequences
|
|
US4683202A
(en)
|
1985-03-28 |
1987-07-28 |
Cetus Corporation |
Process for amplifying nucleic acid sequences
|
|
US4730006A
(en)
|
1986-01-27 |
1988-03-08 |
Merrell Dow Pharmaceuticals Inc. |
Derivatives of 2,6-diamino-3-haloheptanedioic acid
|
|
US4886499A
(en)
|
1986-12-18 |
1989-12-12 |
Hoffmann-La Roche Inc. |
Portable injection appliance
|
|
GB8704027D0
(en)
|
1987-02-20 |
1987-03-25 |
Owen Mumford Ltd |
Syringe needle combination
|
|
US4941880A
(en)
|
1987-06-19 |
1990-07-17 |
Bioject, Inc. |
Pre-filled ampule and non-invasive hypodermic injection device assembly
|
|
US4790824A
(en)
|
1987-06-19 |
1988-12-13 |
Bioject, Inc. |
Non-invasive hypodermic injection device
|
|
US4940460A
(en)
|
1987-06-19 |
1990-07-10 |
Bioject, Inc. |
Patient-fillable and non-invasive hypodermic injection device assembly
|
|
US5339163A
(en)
|
1988-03-16 |
1994-08-16 |
Canon Kabushiki Kaisha |
Automatic exposure control device using plural image plane detection areas
|
|
WO1989009233A1
(en)
|
1988-03-24 |
1989-10-05 |
Terrapin Technologies, Inc. |
Molecular sticks for controlling protein conformation
|
|
US5094951A
(en)
|
1988-06-21 |
1992-03-10 |
Chiron Corporation |
Production of glucose oxidase in recombinant systems
|
|
FR2638359A1
(fr)
|
1988-11-03 |
1990-05-04 |
Tino Dalto |
Guide de seringue avec reglage de la profondeur de penetration de l'aiguille dans la peau
|
|
US5384309A
(en)
*
|
1989-07-17 |
1995-01-24 |
Genentech, Inc. |
Cyclized peptides and their use as platelet aggregation inhibitors
|
|
US5120859A
(en)
|
1989-09-22 |
1992-06-09 |
Genentech, Inc. |
Chimeric amino acid analogues
|
|
US5650133A
(en)
|
1990-01-19 |
1997-07-22 |
Nycomed Salutar |
Macrocyclic polyaza dichelates linked through ring nitrogens via an amide or ester functionality
|
|
US5712418A
(en)
|
1989-10-23 |
1998-01-27 |
Research Corporation Technologies, Inc. |
Synthesis and use of amino acid fluorides as peptide coupling reagents
|
|
US5064413A
(en)
|
1989-11-09 |
1991-11-12 |
Bioject, Inc. |
Needleless hypodermic injection device
|
|
US5312335A
(en)
|
1989-11-09 |
1994-05-17 |
Bioject Inc. |
Needleless hypodermic injection device
|
|
US5245009A
(en)
|
1990-03-23 |
1993-09-14 |
The Salk Institute For Biological Studies |
CRF antagonists
|
|
CA2047042A1
(en)
|
1990-07-19 |
1992-01-20 |
John Hannah |
Cyclic hiv principal neutralizing determinant peptides
|
|
US5190521A
(en)
|
1990-08-22 |
1993-03-02 |
Tecnol Medical Products, Inc. |
Apparatus and method for raising a skin wheal and anesthetizing skin
|
|
WO1992006998A1
(de)
|
1990-10-11 |
1992-04-30 |
Boehringer Ingelheim Kg |
Cyclopeptide, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
|
|
EP0488258B1
(en)
|
1990-11-27 |
1996-04-17 |
Fuji Photo Film Co., Ltd. |
Propenamide derivatives, polymers, copolymers and use thereof
|
|
US5124454A
(en)
|
1990-11-30 |
1992-06-23 |
Minnesota Mining And Manufacturing Company |
Polycyclic diamines and method of preparation
|
|
US5527288A
(en)
|
1990-12-13 |
1996-06-18 |
Elan Medical Technologies Limited |
Intradermal drug delivery device and method for intradermal delivery of drugs
|
|
WO1992013878A2
(en)
|
1991-02-07 |
1992-08-20 |
Board Of Trustees Of The University Of Illinois |
Conformationally restricted mimetics of beta turns and beta bulges and peptides containing the same
|
|
US5747469A
(en)
|
1991-03-06 |
1998-05-05 |
Board Of Regents, The University Of Texas System |
Methods and compositions comprising DNA damaging agents and p53
|
|
US5364851A
(en)
|
1991-06-14 |
1994-11-15 |
International Synthecon, Llc |
Conformationally restricted biologically active peptides, methods for their production and uses thereof
|
|
CA2072249C
(en)
|
1991-06-28 |
2003-06-17 |
Saiko Hosokawa |
Human monoclonal antibody specifically binding to surface antigen of cancer cell membrane
|
|
GB9114949D0
(en)
|
1991-07-11 |
1991-08-28 |
Smithkline Beecham Plc |
Novel compounds
|
|
EP0528312B1
(en)
|
1991-08-13 |
1997-07-16 |
Takeda Chemical Industries, Ltd. |
Cyclic peptides and use thereof
|
|
US7517644B1
(en)
|
1991-08-23 |
2009-04-14 |
Larry J. Smith |
Method and compositions for cellular reprogramming
|
|
GB9118204D0
(en)
|
1991-08-23 |
1991-10-09 |
Weston Terence E |
Needle-less injector
|
|
SE9102652D0
(sv)
|
1991-09-13 |
1991-09-13 |
Kabi Pharmacia Ab |
Injection needle arrangement
|
|
IL103252A
(en)
|
1991-09-30 |
1997-03-18 |
Du Pont Merck Pharma |
CYCLIC COMPOUNDS USEFUL AS INHIBITORS OF PLATELET GLYCOPROTEIN IIb/IIIa AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
|
|
ES2133295T3
(es)
|
1991-11-19 |
1999-09-16 |
Takeda Chemical Industries Ltd |
Peptidos ciclicos y su uso.
|
|
US5328483A
(en)
|
1992-02-27 |
1994-07-12 |
Jacoby Richard M |
Intradermal injection device with medication and needle guard
|
|
JP3067031B2
(ja)
|
1992-04-03 |
2000-07-17 |
カリフォルニア インスティチュート オブ テクノロジー |
オレフィンメタセシス重合方法
|
|
US5411860A
(en)
|
1992-04-07 |
1995-05-02 |
The Johns Hopkins University |
Amplification of human MDM2 gene in human tumors
|
|
ES2139012T3
(es)
|
1992-05-26 |
2000-02-01 |
Univ Leiden |
Peptidos de la proteina p53 humana destinados para ser utilizados en composiciones que inducen una reaccion en los linfocitos t humanos, y linfocitos t citotoxicos especificos de la proteina p53 humana.
|
|
US5323907A
(en)
|
1992-06-23 |
1994-06-28 |
Multi-Comp, Inc. |
Child resistant package assembly for dispensing pharmaceutical medications
|
|
US5383851A
(en)
|
1992-07-24 |
1995-01-24 |
Bioject Inc. |
Needleless hypodermic injection device
|
|
US5569189A
(en)
|
1992-09-28 |
1996-10-29 |
Equidyne Systems, Inc. |
hypodermic jet injector
|
|
US5334144A
(en)
|
1992-10-30 |
1994-08-02 |
Becton, Dickinson And Company |
Single use disposable needleless injector
|
|
EP0691987A1
(en)
|
1993-03-29 |
1996-01-17 |
The Du Pont Merck Pharmaceutical Company |
CYCLIC COMPOUNDS USEFUL AS INHIBITORS OF PLATELET GLYCOPROTEIN IIb/IIIa
|
|
WO1994025482A1
(en)
|
1993-04-23 |
1994-11-10 |
Evans Herbert J |
Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site
|
|
US5446128A
(en)
|
1993-06-18 |
1995-08-29 |
The Board Of Trustees Of The University Of Illinois |
Alpha-helix mimetics and methods relating thereto
|
|
US5622852A
(en)
|
1994-10-31 |
1997-04-22 |
Washington University |
Bcl-x/Bcl-2 associated cell death regulator
|
|
US5536814A
(en)
|
1993-09-27 |
1996-07-16 |
La Jolla Cancer Research Foundation |
Integrin-binding peptides
|
|
CA2177074A1
(en)
|
1993-11-22 |
1995-06-01 |
James R. Bischoff |
P53-binding polypeptides and polynucleotides encoding same
|
|
US6287787B1
(en)
|
1993-11-24 |
2001-09-11 |
Torrey Pines Institute For Molecular Studies |
Dimeric oligopeptide mixture sets
|
|
WO1995022546A1
(en)
|
1994-02-18 |
1995-08-24 |
Cell Therapeutics, Inc. |
Intracellular signalling mediators
|
|
WO1995024176A1
(en)
|
1994-03-07 |
1995-09-14 |
Bioject, Inc. |
Ampule filling device
|
|
US5466220A
(en)
|
1994-03-08 |
1995-11-14 |
Bioject, Inc. |
Drug vial mixing and transfer device
|
|
US5824483A
(en)
|
1994-05-18 |
1998-10-20 |
Pence Inc. |
Conformationally-restricted combinatiorial library composition and method
|
|
US6407059B1
(en)
|
1994-06-08 |
2002-06-18 |
Peptor Limited |
Conformationally constrained backbone cyclized peptide analogs
|
|
IL109943A
(en)
|
1994-06-08 |
2006-08-01 |
Develogen Israel Ltd |
Conformationally constrained backbone cyclized peptide analogs
|
|
US5807746A
(en)
|
1994-06-13 |
1998-09-15 |
Vanderbilt University |
Method for importing biologically active molecules into cells
|
|
US7553929B2
(en)
|
1994-06-13 |
2009-06-30 |
Vanderbilt University |
Cell permeable peptides for inhibition of inflammatory reactions and methods of use
|
|
US5702908A
(en)
|
1994-07-20 |
1997-12-30 |
University Of Dundee |
Interruption of binding of MDM2 and p53 protein and therapeutic application thereof
|
|
US5770377A
(en)
|
1994-07-20 |
1998-06-23 |
University Of Dundee |
Interruption of binding of MDM2 and P53 protein and therapeutic application thereof
|
|
KR970706498A
(ko)
|
1994-09-19 |
1997-11-03 |
리카르도 제이. 모로 |
암의 검사 및 치료방법(detection and treatment of cancer)
|
|
ATE544776T1
(de)
|
1994-12-29 |
2012-02-15 |
Massachusetts Inst Technology |
Chimäre dna-bindeproteine
|
|
US5599302A
(en)
|
1995-01-09 |
1997-02-04 |
Medi-Ject Corporation |
Medical injection system and method, gas spring thereof and launching device using gas spring
|
|
US6169073B1
(en)
|
1995-02-16 |
2001-01-02 |
Bayer Corporation |
Peptides and peptidomimetics with structural similarity to human p53 that activate p53 function
|
|
EP0729972A1
(de)
|
1995-02-28 |
1996-09-04 |
F. Hoffmann-La Roche Ag |
Tetrahydronaphthalin-Peptidderivate
|
|
US6514942B1
(en)
|
1995-03-14 |
2003-02-04 |
The Board Of Regents, The University Of Texas System |
Methods and compositions for stimulating T-lymphocytes
|
|
US5675001A
(en)
|
1995-03-14 |
1997-10-07 |
Hoffman/Barrett, L.L.C. |
Heteroatom-functionalized porphyrazines and multimetallic complexes and polymers derived therefrom
|
|
US6054556A
(en)
|
1995-04-10 |
2000-04-25 |
The Arizona Board Of Regents On Behalf Of The University Of Arizona |
Melanocortin receptor antagonists and agonists
|
|
US5731408A
(en)
|
1995-04-10 |
1998-03-24 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Peptides having potent antagonist and agonist bioactivities at melanocortin receptors
|
|
US5672584A
(en)
|
1995-04-25 |
1997-09-30 |
The University Of Kansas |
Cyclic prodrugs of peptides and peptide nucleic acids having improved metabolic stability and cell membrane permeability
|
|
US6184344B1
(en)
|
1995-05-04 |
2001-02-06 |
The Scripps Research Institute |
Synthesis of proteins by native chemical ligation
|
|
SI0832096T1
(en)
|
1995-05-04 |
2001-12-31 |
Scripps Research Inst |
Synthesis of proteins by native chemical ligation
|
|
US5730723A
(en)
|
1995-10-10 |
1998-03-24 |
Visionary Medical Products Corporation, Inc. |
Gas pressured needle-less injection device and method
|
|
US5817789A
(en)
|
1995-06-06 |
1998-10-06 |
Transkaryotic Therapies, Inc. |
Chimeric proteins for use in transport of a selected substance into cells
|
|
US6051554A
(en)
|
1995-06-07 |
2000-04-18 |
Peptor Limited |
Conformationally constrained backbone cyclized somatostatin analogs
|
|
US5811515A
(en)
|
1995-06-12 |
1998-09-22 |
California Institute Of Technology |
Synthesis of conformationally restricted amino acids, peptides, and peptidomimetics by catalytic ring closing metathesis
|
|
FR2738151B1
(fr)
|
1995-09-04 |
1997-09-26 |
Rhone Poulenc Rorer Sa |
Antagonistes de l'activite oncogenique de la proteine mdm2, et leur utilisation dans le traitement des cancers
|
|
GB9521544D0
(en)
|
1995-10-20 |
1995-12-20 |
Univ Dundee |
Activation of P53 protein and therapeutic applications thereof
|
|
US5840833A
(en)
|
1995-10-27 |
1998-11-24 |
Molecumetics, Ltd |
Alpha-helix mimetics and methods relating thereto
|
|
US5893397A
(en)
|
1996-01-12 |
1999-04-13 |
Bioject Inc. |
Medication vial/syringe liquid-transfer apparatus
|
|
AU6162996A
(en)
|
1996-01-17 |
1997-08-11 |
California Institute Of Technology |
Synthesis of conformationally restricted amino acids, peptides and peptidomimetics by catalytic ring closing metathesis
|
|
US5849954A
(en)
|
1996-01-18 |
1998-12-15 |
Research Corporation Technologies, Inc. |
Method of peptide synthesis
|
|
US5849691A
(en)
|
1996-02-20 |
1998-12-15 |
The United States Of America As Represented By The Department Of Health And Human Services |
Peptidomimetic inhibitors of cathepsin D and plasmepsins I and II
|
|
GB9607549D0
(en)
|
1996-04-11 |
1996-06-12 |
Weston Medical Ltd |
Spring-powered dispensing device
|
|
JP3792777B2
(ja)
|
1996-05-10 |
2006-07-05 |
株式会社カネカ |
１−アルコキシカルボニル−３−フェニルプロピル誘導体の製造方法
|
|
US5817752A
(en)
|
1996-06-06 |
1998-10-06 |
La Jolla Pharmaceutical Company |
Cyclic polypeptides comprising a thioether linkage and methods for their preparation
|
|
US5663316A
(en)
|
1996-06-18 |
1997-09-02 |
Clontech Laboratories, Inc. |
BBC6 gene for regulation of cell death
|
|
EP0958305B1
(en)
|
1996-07-05 |
2008-06-04 |
Cancer Research Technology Limited |
Inhibitions of the interaction between p53 and mdm2
|
|
US7083983B2
(en)
|
1996-07-05 |
2006-08-01 |
Cancer Research Campaign Technology Limited |
Inhibitors of the interaction between P53 and MDM2
|
|
US5955593A
(en)
|
1996-09-09 |
1999-09-21 |
Washington University |
BH3 interacting domain death agonist
|
|
US20020064546A1
(en)
|
1996-09-13 |
2002-05-30 |
J. Milton Harris |
Degradable poly(ethylene glycol) hydrogels with controlled half-life and precursors therefor
|
|
US5965703A
(en)
|
1996-09-20 |
1999-10-12 |
Idun Pharmaceuticals |
Human bad polypeptides, encoding nucleic acids and methods of use
|
|
US5856445A
(en)
|
1996-10-18 |
1999-01-05 |
Washington University |
Serine substituted mutants of BCL-XL /BCL-2 associated cell death regulator
|
|
WO1998017625A1
(en)
|
1996-10-22 |
1998-04-30 |
Daiichi Pharmaceutical Co., Ltd. |
Novel remedies for infectious diseases
|
|
US6271198B1
(en)
|
1996-11-06 |
2001-08-07 |
Genentech, Inc. |
Constrained helical peptides and methods of making same
|
|
AU734337B2
(en)
|
1996-11-21 |
2001-06-14 |
Promega Corporation |
Alkyl peptide amides and applications
|
|
CZ290347B6
(cs)
|
1997-02-07 |
2002-07-17 |
Ústav organické chemie a biochemie AV ČR |
Cyklopeptidy stimulující uvolňování růstového hormonu a způsob jejich přípravy
|
|
CA2281204A1
(en)
|
1997-02-20 |
1998-08-27 |
Yeda Research And Development Co., Ltd. |
Antipathogenic synthetic peptides and compositions comprising them
|
|
US6849428B1
(en)
|
1997-03-05 |
2005-02-01 |
New England Biolabs, Inc. |
Intein-mediated protein ligation of expressed proteins
|
|
JP2002506423A
(ja)
|
1997-04-11 |
2002-02-26 |
イーライ・リリー・アンド・カンパニー |
ペプチド模倣型大員環のコンビナトリアルライブラリーとそのための方法
|
|
GB9708092D0
(en)
|
1997-04-22 |
1997-06-11 |
Univ Dundee |
Materials and methods relating to inhibiting the interaction of p53 and mdm2
|
|
WO1998051707A1
(fr)
|
1997-05-15 |
1998-11-19 |
Kyowa Hakko Kogyo Co., Ltd. |
Peptides a structures cycliques et a effet restaurateur d'activite de la proteine p53 sur les mutants de ladite proteine
|
|
US5993412A
(en)
|
1997-05-19 |
1999-11-30 |
Bioject, Inc. |
Injection apparatus
|
|
WO1999014321A1
(en)
|
1997-09-17 |
1999-03-25 |
The Walter And Eliza Hall Institute Of Medical Research |
Novel therapeutic molecules
|
|
CA2305809A1
(en)
|
1997-09-26 |
1999-04-08 |
University Technologies International, Inc. |
Use of the tumour suppressor gene p33ing1 for modulation of p53 activity and in tumour diagnosis
|
|
US6165732A
(en)
|
1997-10-14 |
2000-12-26 |
Washington University |
Method for identifying apoptosis modulating compounds
|
|
US6875594B2
(en)
|
1997-11-13 |
2005-04-05 |
The Rockefeller University |
Methods of ligating expressed proteins
|
|
WO1999029343A1
(en)
|
1997-12-09 |
1999-06-17 |
Thomas Jefferson University |
Method of treating bladder cancer with wild type vaccinia virus
|
|
JP3786832B2
(ja)
|
1998-01-07 |
2006-06-14 |
デビオ ルシェルシュ ファルマシュティーク ソシエテ アノニム |
分解性のヘテロ二官能性ポリ（エチレングリコール）アクリレート及びそれから誘導されるゲル及び複合体
|
|
IT1298087B1
(it)
|
1998-01-08 |
1999-12-20 |
Fiderm S R L |
Dispositivo per il controllo della profondita' di penetrazione di un ago, in particolare applicabile ad una siringa per iniezioni
|
|
US6030997A
(en)
|
1998-01-21 |
2000-02-29 |
Eilat; Eran |
Acid labile prodrugs
|
|
AU767185B2
(en)
|
1998-03-23 |
2003-11-06 |
President And Fellows Of Harvard College |
Synthesis of compounds and libraries of compounds
|
|
HUP0101629A2
(en)
|
1998-04-15 |
2003-03-28 |
Aventis Pharma Inc |
Process for the preparation of resin-bound cyclic peptides
|
|
WO1999063929A2
(en)
|
1998-06-08 |
1999-12-16 |
Advanced Medicine, Inc. |
Multibinding inhibitors of microsomal triglyceride transferase protein
|
|
US6326354B1
(en)
|
1998-08-19 |
2001-12-04 |
Washington University |
Modulation of apoptosis with bid
|
|
US7173005B2
(en)
|
1998-09-02 |
2007-02-06 |
Antyra Inc. |
Insulin and IGF-1 receptor agonists and antagonists
|
|
US6572856B1
(en)
|
1998-09-10 |
2003-06-03 |
The University Of Virginia Patent Foundation |
Methods for the prevention and treatment of cancer using anti-C3b(i) antibodies
|
|
NZ513487A
(en)
|
1999-01-29 |
2003-02-28 |
Univ Illinois |
The use of a P53 inhibitor for the treatment of cancer, hyperthermia, hypoxia, a burn, trauma to the central nervous system, a seizure, acute inflammation, tissue ageing, preservation of organs for transplant and preparation of a host for bone marrow transplant
|
|
US6372490B1
(en)
|
1999-02-23 |
2002-04-16 |
Curagen Corporation |
Nucleic acid encoding the MDM interacting protein
|
|
JP2003503008A
(ja)
|
1999-03-01 |
2003-01-28 |
バリアジェニックス インコーポレーテッド |
Ｒｎａ分子をターゲティングする方法
|
|
HK1040062A1
(zh)
*
|
1999-03-03 |
2002-05-24 |
Eli Lilly And Company |
含有成胶束表面活性剂的棘白菌素药物配方
|
|
DK1165613T3
(da)
|
1999-03-29 |
2008-08-25 |
Procter & Gamble |
Melanocortinreceptorligander
|
|
US6444425B1
(en)
|
1999-04-02 |
2002-09-03 |
Corixa Corporation |
Compounds for therapy and diagnosis of lung cancer and methods for their use
|
|
US6713280B1
(en)
|
1999-04-07 |
2004-03-30 |
Thomas Jefferson University |
Enhancement of peptide cellular uptake
|
|
US7192713B1
(en)
|
1999-05-18 |
2007-03-20 |
President And Fellows Of Harvard College |
Stabilized compounds having secondary structure motifs
|
|
ATE340560T1
(de)
|
1999-05-24 |
2006-10-15 |
Introgen Therapeutics Inc |
Verfahren und zusammensetzungen für nichtvirale gentherapie zur behandlung von hyperproliferativen krankheiten
|
|
US6831155B2
(en)
|
1999-12-08 |
2004-12-14 |
President And Fellows Of Harvard College |
Inhibition of p53 degradation
|
|
US6348558B1
(en)
|
1999-12-10 |
2002-02-19 |
Shearwater Corporation |
Hydrolytically degradable polymers and hydrogels made therefrom
|
|
ATE319996T1
(de)
|
1999-12-16 |
2006-03-15 |
Chugai Pharmaceutical Co Ltd |
Verfahren zum auffinden eines heilmittels für krebs mit hilfe von interaktionsdomänen von p53 und mortalin
|
|
DE10009341A1
(de)
|
2000-02-22 |
2001-09-06 |
Florian Kern |
Verfahren zur antigen-spezifischen Stimulation von T-Lymphozyten
|
|
US6495674B1
(en)
|
2000-02-25 |
2002-12-17 |
The Salk Institute For Biological Studies |
Evectins and their use
|
|
US7166712B2
(en)
|
2000-07-12 |
2007-01-23 |
Philadelphia, Health And Education Corporation |
Mammalian MDM2 binding proteins and uses thereof
|
|
US7049290B2
(en)
|
2000-07-28 |
2006-05-23 |
Universität Zürich |
Essential downstream component of the wingless signaling pathway and therapeutic and diagnostic applications based thereon
|
|
US20040228866A1
(en)
|
2000-08-04 |
2004-11-18 |
Ludwig Institute For Cancer Research |
Suppressor genes
|
|
AU2001284942A1
(en)
|
2000-08-16 |
2002-02-25 |
Georgetown University Medical Center |
Small molecule inhibitors targeted at bcl-2
|
|
EE200300089A
(et)
|
2000-09-08 |
2005-02-15 |
Gryphon Therapeutics, Inc. |
Sünteetilised erütropoeesi stimuleerivad valgud, nende valmistamismeetodid ning kasutamine
|
|
CA2432111A1
(en)
|
2000-12-19 |
2002-08-22 |
The Johns Hopkins University |
Jfy1 protein induces rapid apoptosis
|
|
ES2527339T3
(es)
|
2001-02-23 |
2015-01-23 |
Polyphor Ltd. |
Peptidomiméticos fijados a patrón con actividad antimicrobiana
|
|
GB0104588D0
(en)
|
2001-02-24 |
2001-04-11 |
Univ Dundee |
Novel p-53 inducible protein
|
|
DE10109813A1
(de)
|
2001-03-01 |
2002-09-12 |
Thomas Stanislawski |
Tumor-Peptidantigen aus humanem mdm2 Proto-Onkogen
|
|
WO2002072597A2
(en)
|
2001-03-09 |
2002-09-19 |
University Of Louisville |
Helicomimetics and stabilized lxxll peptidomimetics
|
|
EP1422215A4
(en)
|
2001-08-08 |
2005-07-06 |
Kaneka Corp |
PROCESS FOR PRODUCING OPTICALLY ACTIVE 2-SUBSTITUTED CARBOXYLIC ACID
|
|
US20040106548A1
(en)
|
2001-09-07 |
2004-06-03 |
Schmidt Michelle A |
Conformationally constrained labeled peptides for imaging and therapy
|
|
US20020045192A1
(en)
|
2001-09-19 |
2002-04-18 |
St. Jude Children's Research Hospital |
Arf and HDM2 interaction domains and methods of use thereof
|
|
CN101157924A
(zh)
|
2001-12-11 |
2008-04-09 |
人体基因组科学有限公司 |
嗜中性白细胞因子α
|
|
EP1321474A1
(en)
|
2001-12-18 |
2003-06-25 |
Universite De Geneve |
A method for inducing apoptosis
|
|
AU2002364364A1
(en)
|
2001-12-31 |
2003-07-24 |
Dana-Farber Cancer Institute, Inc. |
Method of treating apoptosis and compositions thereof
|
|
EP1468013A4
(en)
|
2002-01-03 |
2005-03-16 |
Yissum Res Dev Co |
CYCLIC PEPTIDES WITH CARBON SKELETON HAVING RESTRICTED CONFORMATION
|
|
WO2003070892A2
(en)
|
2002-02-15 |
2003-08-28 |
The Regents Of The University Of Michigan |
Inhibitors of rgs proteins
|
|
US20030166138A1
(en)
|
2002-02-21 |
2003-09-04 |
Todd Kinsella |
Cyclic peptides and analogs useful to treat allergies
|
|
US7498134B2
(en)
|
2002-03-30 |
2009-03-03 |
The Trustees Of Columbia University In The City Of New York |
HAUSP-Mdm2 interaction and uses thereof
|
|
US7524630B2
(en)
|
2002-04-22 |
2009-04-28 |
University Of Florida Research Foundation, Inc. |
Functionalized nanoparticles and methods of use
|
|
WO2003095625A2
(en)
|
2002-05-13 |
2003-11-20 |
3-Dimensional Pharmaceuticals, Inc. |
Method for cytoprotection through mdm2 and hdm2 inhibition
|
|
AU2003247435A1
(en)
|
2002-05-30 |
2003-12-19 |
European Molecular Biology Laboratory |
Combinatorial chemical library ii
|
|
AU2003240482B2
(en)
|
2002-05-30 |
2009-03-12 |
The Scripps Research Institute |
Copper-catalysed ligation of azides and acetylenes
|
|
US7208154B2
(en)
|
2002-06-03 |
2007-04-24 |
Regents Of The University Of Michigan |
Methods and compositions for the treatment of MHC-associated conditions
|
|
SE0201863D0
(en)
|
2002-06-18 |
2002-06-18 |
Cepep Ab |
Cell penetrating peptides
|
|
WO2004022766A1
(ja)
|
2002-09-06 |
2004-03-18 |
Kaneka Corporation |
Ｌ−αーメチルシステイン誘導体の製造方法
|
|
WO2004022580A2
(en)
|
2002-09-09 |
2004-03-18 |
Dana-Farber Cancer Institute, Inc. |
Bh3 peptides and method of use thereof
|
|
AU2003277891A1
(en)
|
2002-09-23 |
2004-04-08 |
Medivir Ab |
Hcv ns-3 serine protease inhibitors
|
|
ATE425183T1
(de)
|
2002-10-07 |
2009-03-15 |
Ludwig Inst For Cancer Res Ltd |
P53-bindendes polypeptid
|
|
CN101003459B
(zh)
|
2002-10-24 |
2011-08-10 |
陶氏环球技术有限责任公司 |
烯烃易位产物混合物的稳定
|
|
ES2336911T3
(es)
|
2002-11-07 |
2010-04-19 |
Kosan Biosciences, Inc. |
Trans-9,10-dehidroepotilonas c y d, sus analogos y procedimientos de preparacion.
|
|
CN1711084B
(zh)
|
2002-11-08 |
2010-04-28 |
霍夫曼-拉罗奇有限公司 |
作为ppar激动剂的取代4-烷氧基噁唑衍生物
|
|
US20050227932A1
(en)
|
2002-11-13 |
2005-10-13 |
Tianbao Lu |
Combinational therapy involving a small molecule inhibitor of the MDM2: p53 interaction
|
|
US7166575B2
(en)
|
2002-12-17 |
2007-01-23 |
Nastech Pharmaceutical Company Inc. |
Compositions and methods for enhanced mucosal delivery of peptide YY and methods for treating and preventing obesity
|
|
WO2004058804A1
(en)
|
2002-12-24 |
2004-07-15 |
Walter And Eliza Hall Institute Of Medical Research |
Peptides and therapeutic uses thereof
|
|
US20040231909A1
(en)
|
2003-01-15 |
2004-11-25 |
Tai-Yang Luh |
Motorized vehicle having forward and backward differential structure
|
|
US20060159692A1
(en)
|
2003-02-26 |
2006-07-20 |
Yoichi Taya |
Transcriptional factor inducing apoptosis in cancer cell
|
|
EP1452868A2
(en)
|
2003-02-27 |
2004-09-01 |
Pepscan Systems B.V. |
Method for selecting a candidate drug compound
|
|
US7632920B2
(en)
|
2003-04-10 |
2009-12-15 |
Schering Corporation |
Soluble, stable form of HDM2, crystalline forms thereof and methods of use thereof
|
|
AU2003902743A0
(en)
|
2003-06-02 |
2003-06-19 |
Promics Pty Limited |
Process for the preparation of cyclic peptides
|
|
WO2005000876A2
(en)
|
2003-06-27 |
2005-01-06 |
Proteologics, Inc. |
Ring finger family proteins and uses related thereto
|
|
WO2005007675A2
(en)
|
2003-07-09 |
2005-01-27 |
The Scripps Research Institute |
TRIAZOLE ϵ-AMINO ACIDS
|
|
GB0317815D0
(en)
|
2003-07-30 |
2003-09-03 |
Amersham Health As |
Imaging agents
|
|
WO2005019440A1
(en)
|
2003-08-20 |
2005-03-03 |
Northern Sydney And Central Coast Area Health Service |
Methods for enhancing embryo viability
|
|
AU2004277981B2
(en)
|
2003-10-03 |
2009-10-01 |
Merck & Co., Inc. |
Benzylether and benzylamino beta-secretase inhibitors for the treatment of Alzheimer's disease
|
|
US20070207947A1
(en)
|
2003-10-16 |
2007-09-06 |
Aplagen Gmbh |
Stabilized Peptides
|
|
WO2005044840A2
(en)
|
2003-10-17 |
2005-05-19 |
The Cbr Institute For Biomedical Research, Inc. |
Modulation of anergy and methods for isolating anergy-modulating compounds
|
|
US7273927B2
(en)
|
2003-11-03 |
2007-09-25 |
University Of Massachusetts |
Mdm2 splice variants
|
|
EP1997828B1
(en)
|
2003-11-05 |
2017-10-04 |
Dana-Farber Cancer Institute, Inc. |
Stabilized alpha helical peptides from BCL-2 and uses thereof
|
|
US7772367B2
(en)
|
2004-01-30 |
2010-08-10 |
The Trustees Of Columbia University In The City Of New York |
C-terminal p53 palindromic peptide that induces apoptosis of cells with aberrant p53 and uses thereof
|
|
GB0404731D0
(en)
|
2004-03-03 |
2004-04-07 |
Indp Administrative Inst Nims |
Method and products for the selective degradation of proteins
|
|
WO2005090388A1
(en)
|
2004-03-19 |
2005-09-29 |
The University Of Queensland |
Alpha helical mimics, their uses and methods for their production
|
|
BRPI0511328A
(pt)
|
2004-05-18 |
2007-12-04 |
Hoffmann La Roche |
cis-imidazolinas
|
|
WO2005118620A2
(en)
|
2004-05-27 |
2005-12-15 |
New York University |
Methods for preparing internally constraied peptides and peptidomimetics
|
|
WO2005118634A2
(en)
|
2004-06-04 |
2005-12-15 |
The Brigham And Women's Hospital, Inc. |
Helical peptidomimetics with enhanced activity against beta-amyloid production
|
|
CN100335467C
(zh)
|
2004-06-04 |
2007-09-05 |
中国科学院上海有机化学研究所 |
一锅法区域选择性合成5－碘代－1，4－二取代－1，2，3－三氮唑化合物
|
|
EP1602663A1
(en)
|
2004-06-04 |
2005-12-07 |
Chiralix B.V. |
Triazole-linked glycoamino acids and glycopeptides
|
|
US7893278B2
(en)
|
2004-06-17 |
2011-02-22 |
Hoffman-La Roche Inc. |
CIS-imidazolines
|
|
KR101699142B1
(ko)
|
2004-06-18 |
2017-01-23 |
암브룩스, 인코포레이티드 |
신규 항원-결합 폴리펩티드 및 이의 용도
|
|
US7674787B2
(en)
|
2004-07-09 |
2010-03-09 |
The Regents Of The University Of Michigan |
Conformationally constrained Smac mimetics and the uses thereof
|
|
US9598470B2
(en)
|
2004-10-07 |
2017-03-21 |
Craig W. Beattie |
Compositions and methods to prevent cancer by stabilizing P53 through non MDM2-mediated pathways
|
|
EP1814860B1
(en)
|
2004-10-29 |
2009-06-03 |
Schering Corporation |
Substituted 5-carboxyamide pyrazoles and [1,2,4]triazoles as antiviral agents
|
|
US20060148715A1
(en)
|
2004-12-20 |
2006-07-06 |
Baylor College Of Medicine |
Structural requirements for STAT3 binding and recruitment to phosphotyrosine ligands
|
|
GB0428187D0
(en)
|
2004-12-23 |
2005-01-26 |
Univ Liverpool |
Cancer treatment
|
|
DK1844337T3
(da)
|
2005-01-24 |
2013-09-30 |
Pepscan Systems Bv |
Bindingsforbindelser, immunogene forbindelser og peptidmimetika
|
|
FR2881430B1
(fr)
|
2005-02-01 |
2010-10-22 |
Servier Lab |
Nouveaux peptides interagissant avec les membres anti-apoptotiques de la famille de proteines bcl-2 et utilisations
|
|
SG176463A1
(en)
|
2005-02-22 |
2011-12-29 |
Univ Michigan |
Small molecule inhibitors of mdm2 and uses thereof
|
|
WO2006103666A2
(en)
|
2005-03-28 |
2006-10-05 |
Yeda Research And Development Co. Ltd. |
Isolated bid polypeptides, polynucleotides encoding same and antibodies directed thereagainst and methods of using same for inducing cell cycle arrest or apoptosis
|
|
EP1891090A2
(en)
|
2005-06-13 |
2008-02-27 |
Tranzyme Pharma, Inc. |
Macrocyclic ghrelin receptor antagonists and inverse agonists and methods of using the same
|
|
MX2007015895A
(es)
*
|
2005-06-17 |
2008-03-04 |
Baxter Int |
Composiciones farmaceuticas, amortiguadas por estabilidad que incluyen peptidos tipo motilin.
|
|
US20070020620A1
(en)
|
2005-07-14 |
2007-01-25 |
Finn M G |
Compositions and methods for coupling a plurality of compounds to a scaffold
|
|
WO2007009191A1
(en)
|
2005-07-21 |
2007-01-25 |
Newsouth Innovations Pty Limited |
Method for treating cancer
|
|
US20070161544A1
(en)
|
2006-01-06 |
2007-07-12 |
Peter Wipf |
Selective targeting agents for mitcochondria
|
|
US7745573B2
(en)
|
2006-02-17 |
2010-06-29 |
Polychip Pharmaceuticals Pty Ltd. |
Conotoxin analogues and methods for synthesis of intramolecular dicarba bridge-containing peptides
|
|
US7538190B2
(en)
|
2006-02-17 |
2009-05-26 |
Polychip Pharmaceuticals Pty Ltd |
Methods for the synthesis of two or more dicarba bridges in organic compounds
|
|
GB0611405D0
(en)
|
2006-06-09 |
2006-07-19 |
Univ Belfast |
FKBP-L: A novel inhibitor of angiogenesis
|
|
CN101595107A
(zh)
|
2006-06-30 |
2009-12-02 |
先灵公司 |
能提高p53活性的有取代哌啶及其用途
|
|
CA2656393A1
(en)
|
2006-06-30 |
2008-01-10 |
Schering Corporation |
Method of using substituted piperidines that increase p53 activity
|
|
CA2659225A1
(en)
|
2006-07-26 |
2008-01-31 |
Pepscan Systems B.V. |
Immunogenic compounds and protein mimics
|
|
US8614192B2
(en)
|
2006-07-28 |
2013-12-24 |
Leiden University Medical Center |
Method for treating ocular cancer
|
|
US7737174B2
(en)
|
2006-08-30 |
2010-06-15 |
The Regents Of The University Of Michigan |
Indole inhibitors of MDM2 and the uses thereof
|
|
EP2099445B1
(en)
|
2006-09-04 |
2010-11-17 |
University Court of The University of Dundee |
P53 activating benzoyl urea and benzoyl thiourea compounds
|
|
WO2008033557A2
(en)
|
2006-09-15 |
2008-03-20 |
Siemens Medical Solutions Usa, Inc. |
Click chemistry-derived cyclic peptidomimetics as integrin markers
|
|
US7897394B2
(en)
|
2006-09-21 |
2011-03-01 |
Intrexon Corporation |
Endoplasmic reticulum localization signals
|
|
WO2008034736A2
(en)
|
2006-09-21 |
2008-03-27 |
F. Hoffmann-La Roche Ag |
Oxindole derivatives as anticancer agents
|
|
AU2007307254A1
(en)
|
2006-10-05 |
2008-04-17 |
New York Blood Center, Inc. |
Stabilized therapeutic small helical antiviral peptides
|
|
WO2008061192A2
(en)
|
2006-11-15 |
2008-05-22 |
Dana-Farber Cancer Institute, Inc. |
Stabilized maml peptides and uses thereof
|
|
US7932397B2
(en)
|
2006-11-22 |
2011-04-26 |
Massachusetts Institute Of Technology |
Olefin metathesis catalysts and related methods
|
|
CN105061577A
(zh)
|
2006-12-14 |
2015-11-18 |
爱勒让治疗公司 |
双巯基大环化系统
|
|
US7981998B2
(en)
|
2006-12-14 |
2011-07-19 |
Aileron Therapeutics, Inc. |
Bis-sulfhydryl macrocyclization systems
|
|
AU2007336132A1
(en)
|
2006-12-21 |
2008-06-26 |
Cytos Biotechnology Ag |
Circular CCR5 peptide conjugates and uses thereof
|
|
WO2008092281A1
(en)
|
2007-01-29 |
2008-08-07 |
Polyphor Ltd. |
Template-fixed peptidomimetics
|
|
EP2952522B1
(en)
|
2007-01-31 |
2019-10-30 |
Dana-Farber Cancer Institute, Inc. |
Stabilized p53 peptides and uses thereof
|
|
CN101244053B
(zh)
|
2007-02-16 |
2010-12-08 |
石药集团中奇制药技术（石家庄）有限公司 |
以多西他赛为主组分的新的分散体系
|
|
ES2398310T3
(es)
|
2007-02-23 |
2013-03-15 |
Aileron Therapeutics, Inc. |
Péptidos macrocíclicos unidos a triazol
|
|
WO2008106507A2
(en)
|
2007-02-27 |
2008-09-04 |
University Of South Florida |
Mdm2/mdmx inhibitor peptide
|
|
AU2008232709C1
(en)
|
2007-03-28 |
2015-01-15 |
President And Fellows Of Harvard College |
Stitched polypeptides
|
|
JP5883220B2
(ja)
|
2007-05-02 |
2016-03-09 |
デイナ ファーバー キャンサー インスティチュート，インコーポレイテッド |
細胞のホメオスタシス経路および細胞の生存を調節する方法
|
|
JP2010530846A
(ja)
*
|
2007-06-01 |
2010-09-16 |
アコロジックス インコーポレイティッド |
高温で安定なペプチド製剤
|
|
WO2009002481A1
(en)
*
|
2007-06-26 |
2008-12-31 |
Merck & Co., Inc. |
Lyophilized anti-fungal composition
|
|
ATE547415T1
(de)
|
2007-09-21 |
2012-03-15 |
Janssen Pharmaceutica Nv |
Inhibitoren der wechselwirkung zwischen mdm2 und p53
|
|
JP5783721B2
(ja)
|
2007-09-26 |
2015-09-24 |
ダナ ファーバー キャンサー インスティテュート インコーポレイテッド |
Ｂｃｌ−２ファミリーポリペプチドを調節する方法及び組成物
|
|
WO2009110952A2
(en)
|
2007-12-31 |
2009-09-11 |
New York University |
Control of viral-host membrane fusion with hydrogen bond surrogate-based artificial helices
|
|
ES2563027T3
(es)
|
2008-01-07 |
2016-03-10 |
Amgen Inc. |
Método para fabricación de moléculas heterodímeras Fc de anticuerpos utilizando efectos de conducción electrostática
|
|
BRPI0906685A2
(pt)
|
2008-01-25 |
2016-10-11 |
Massachusetts Inst Technology |
catalisadores para reações de metátese incluindo metátese de olefina enantiosseletiva, e métodos relacionados
|
|
MX2010008168A
(es)
|
2008-01-25 |
2011-02-24 |
P53 Inc |
Biomarcadores p53.
|
|
KR20100126361A
(ko)
|
2008-02-08 |
2010-12-01 |
에일러론 테라퓨틱스 인코포레이티드 |
치료용 펩티드유사 거대고리
|
|
WO2009126292A2
(en)
|
2008-04-08 |
2009-10-15 |
Aileron Therapeutics, Inc. |
Biologically active peptidomimetic macrocycles
|
|
US20110144303A1
(en)
|
2008-04-08 |
2011-06-16 |
Aileron Therapeutics, Inc. |
Biologically Active Peptidomimetic Macrocycles
|
|
CA2725227A1
(en)
|
2008-05-06 |
2009-11-12 |
Asim Kumar Debnath |
Antiviral cell penetrating peptides
|
|
WO2009149214A2
(en)
|
2008-06-03 |
2009-12-10 |
Aileron Therapeutics, Inc. |
Compositions and methods for enhancing cellular transport of biomolecules
|
|
US8343760B2
(en)
|
2008-06-05 |
2013-01-01 |
University Of Maryland, Baltimore |
p53 activator peptides
|
|
WO2010011313A2
(en)
|
2008-07-23 |
2010-01-28 |
President And Fellows Of Harvard College |
Ligation of stapled polypeptides
|
|
GB0813873D0
(en)
|
2008-07-30 |
2008-09-03 |
Univ Dundee |
Compounds
|
|
US8583380B2
(en)
|
2008-09-05 |
2013-11-12 |
Aueon, Inc. |
Methods for stratifying and annotating cancer drug treatment options
|
|
US8586707B2
(en)
|
2008-09-16 |
2013-11-19 |
The Research Foundation Of State University Of New York |
Stapled peptides and method of synthesis
|
|
US9399666B2
(en)
|
2008-09-18 |
2016-07-26 |
New York University |
Inhibiting interaction between the HIF-1ALPHA and p300/CBP with hydrogen bond surrogate-based helices
|
|
EP2331567A1
(en)
|
2008-09-22 |
2011-06-15 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
|
CN102884074A
(zh)
*
|
2008-09-22 |
2013-01-16 |
爱勒让治疗公司 |
拟肽大环化合物
|
|
CN102203126A
(zh)
|
2008-09-22 |
2011-09-28 |
爱勒让治疗公司 |
用于制备纯化的多肽组合物的方法
|
|
AU2009294871A1
(en)
|
2008-09-22 |
2010-03-25 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
|
EP2329015A1
(en)
|
2008-09-22 |
2011-06-08 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
|
ES2666458T3
(es)
|
2008-09-22 |
2018-05-04 |
Aileron Therapeutics, Inc. |
Macrociclos peptidomiméticos
|
|
US20110218155A1
(en)
|
2008-10-10 |
2011-09-08 |
Dana-Farber Cancer Institute, Inc. |
Chemical modulators of pro-apoptotic bax and bcl-2 polypeptides
|
|
JP2010120881A
(ja)
|
2008-11-19 |
2010-06-03 |
Keio Gijuku |
ヒト癌タンパク質ＭＤＭ２とヒト癌抑制タンパク質ｐ５３との相互作用阻害ペプチド及びその使用
|
|
KR101298168B1
(ko)
|
2008-11-21 |
2013-08-20 |
충남대학교산학협력단 |
스네일―ｐ５３ 간의 결합을 저해하는 화합물 및 이를 유효성분으로 함유하는 암질환 치료제
|
|
EP2352507A4
(en)
|
2008-11-24 |
2012-04-25 |
Aileron Therapeutics Inc |
PEPTIDOMIMETIC MACROCYCLES WITH IMPROVED PROPERTIES
|
|
US9079970B2
(en)
|
2008-12-09 |
2015-07-14 |
Dana Farber Cancer Institute, Inc. |
Methods and compositions for specific modulation of MCL-1
|
|
WO2010083347A2
(en)
|
2009-01-14 |
2010-07-22 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
|
WO2010083501A2
(en)
|
2009-01-16 |
2010-07-22 |
University Of South Florida |
Alpha-helix mimetic using a 2,5-oligopyrimidine scaffold
|
|
US8217051B2
(en)
|
2009-02-17 |
2012-07-10 |
Hoffmann-La Roche Inc. |
Spiroindolinone derivatives
|
|
FR2942798B1
(fr)
|
2009-03-05 |
2011-04-08 |
Centre Nat Rech Scient |
Peptides utilisables pour le traitement de la leucemie lymphoide chronique
|
|
US20120135089A1
(en)
|
2009-03-17 |
2012-05-31 |
Stockwell Brent R |
E3 ligase inhibitors
|
|
US8076482B2
(en)
|
2009-04-23 |
2011-12-13 |
Hoffmann-La Roche Inc. |
3,3′-spiroindolinone derivatives
|
|
WO2011005219A1
(en)
|
2009-07-07 |
2011-01-13 |
Agency For Science, Technology And Research |
Novel mdm2 binding peptides and uses thereof
|
|
JP2012532929A
(ja)
|
2009-07-13 |
2012-12-20 |
プレジデント アンド フェロウズ オブ ハーバード カレッジ |
二機能性のステープリングされたポリペプチドおよびそれらの使用
|
|
WO2011023677A1
(en)
|
2009-08-26 |
2011-03-03 |
Novartis Ag |
Tetra-substituted heteroaryl compounds and their use as mdm2 and/or mdm4 modulators
|
|
US20130072439A1
(en)
|
2009-09-22 |
2013-03-21 |
Huw M. Nash |
Peptidomimetic macrocycles
|
|
US8017607B2
(en)
|
2009-10-14 |
2011-09-13 |
Hoffmann-La Roche Inc. |
N-substituted-pyrrolidines as inhibitors of MDM2-P-53 interactions
|
|
US20110223149A1
(en)
|
2009-10-14 |
2011-09-15 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
|
WO2011056961A2
(en)
|
2009-11-04 |
2011-05-12 |
Health Research Inc. |
Method and compositions for suppression of aging
|
|
KR20120099462A
(ko)
|
2009-11-12 |
2012-09-10 |
더 리젠츠 오브 더 유니버시티 오브 미시건 |
스피로-옥신돌 ｍｄｍ2 길항제
|
|
US20110118283A1
(en)
|
2009-11-17 |
2011-05-19 |
Qingjie Ding |
Substituted Pyrrolidine-2-Carboxamides
|
|
US8088815B2
(en)
|
2009-12-02 |
2012-01-03 |
Hoffman-La Roche Inc. |
Spiroindolinone pyrrolidines
|
|
CU24130B1
(es)
|
2009-12-22 |
2015-09-29 |
Novartis Ag |
Isoquinolinonas y quinazolinonas sustituidas
|
|
US8440693B2
(en)
|
2009-12-22 |
2013-05-14 |
Novartis Ag |
Substituted isoquinolinones and quinazolinones
|
|
US8658170B2
(en)
|
2010-01-06 |
2014-02-25 |
Joseph P. Errico |
Combination therapy with MDM2 and EFGR inhibitors
|
|
KR101220516B1
(ko)
|
2010-01-21 |
2013-01-10 |
연세대학교 산학협력단 |
항－ｍｄｍ２를 발현하는 인간 성체줄기세포 및 그의 용도
|
|
EP2534140B1
(en)
|
2010-02-08 |
2018-04-11 |
Trustees of Boston College |
Efficient methods for z- or cis-selective cross-metathesis
|
|
US8288431B2
(en)
|
2010-02-17 |
2012-10-16 |
Hoffmann-La Roche Inc. |
Substituted spiroindolinones
|
|
WO2011106650A2
(en)
|
2010-02-27 |
2011-09-01 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Novel p53-mdm2/p53-mdm4 antagonists to treat proliferative disease
|
|
SG184288A1
(en)
|
2010-04-09 |
2012-11-29 |
Univ Michigan |
Biomarkers for mdm2 inhibitors for use in treating disease
|
|
US20110313167A1
(en)
|
2010-06-22 |
2011-12-22 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Substituted Heterocycles as Therapeutic agents for treating cancer
|
|
WO2011163423A2
(en)
|
2010-06-22 |
2011-12-29 |
University Of Central Florida Research Foundation, Inc. |
Methods and compositions for cell permeable stat3 inhibitor
|
|
US8907053B2
(en)
|
2010-06-25 |
2014-12-09 |
Aurigene Discovery Technologies Limited |
Immunosuppression modulating compounds
|
|
WO2012016186A1
(en)
|
2010-07-29 |
2012-02-02 |
President And Fellows Of Harvard College |
Macrocyclic kinase inhibitors and uses thereof
|
|
KR20170058446A
(ko)
|
2010-08-13 |
2017-05-26 |
에일러론 테라퓨틱스 인코포레이티드 |
펩티도미메틱 거대고리
|
|
EP2614051A4
(en)
|
2010-09-08 |
2014-01-29 |
Univ Pittsburgh |
P53-MDM2 ANTAGONISTS
|
|
US20120065210A1
(en)
|
2010-09-15 |
2012-03-15 |
Xin-Jie Chu |
Substituted hexahydropyrrolo[1,2-c]imidazolones
|
|
US20120071499A1
(en)
|
2010-09-20 |
2012-03-22 |
Xin-Jie Chu |
Substituted Spiro[3H-Indole-3,6'(5'H)-[1H]Pyrrolo[1,2c]Imidazole-1',2(1H,2'H)-diones
|
|
WO2012040459A2
(en)
|
2010-09-22 |
2012-03-29 |
President And Fellows Of Harvard College |
Beta-catenin targeting peptides and uses thereof
|
|
US20130225603A1
(en)
|
2010-09-27 |
2013-08-29 |
Serrata Llc |
Mdm2 inhibitors for treatment of ocular conditions
|
|
EP2621275B1
(en)
|
2010-09-30 |
2018-03-28 |
St. Jude Children's Research Hospital |
Aryl-substituted imidazoles
|
|
US9169295B2
(en)
|
2010-10-13 |
2015-10-27 |
Bristol-Myers Squibb Company |
Macrocycles and macrocycle stabilized peptides
|
|
FR2967072B1
(fr)
|
2010-11-05 |
2013-03-29 |
Univ Dundee |
Procede pour ameliorer la production de virus et semences vaccinales influenza
|
|
JP2014502152A
(ja)
|
2010-11-12 |
2014-01-30 |
ダナ ファーバー キャンサー インスティテュート，インコーポレイテッド |
癌の治療及び診断
|
|
AU2011326395B2
(en)
|
2010-11-12 |
2016-01-07 |
Ascenta Licensing Corporation |
Spiro-oxindole MDM2 antagonists
|
|
WO2012076513A1
(en)
|
2010-12-09 |
2012-06-14 |
F. Hoffmann-La Roche Ag |
3-cyano-1-hydroxymethyl-2-phenylpyrrolidine derivatives as inhibitors of mdm2-p53 interactions useful for the treatment of cancer
|
|
US9029332B2
(en)
|
2010-12-15 |
2015-05-12 |
The Research Foundation For The State University Of New York |
Cross-linked peptides and proteins, methods of making same, and uses thereof
|
|
MX2013006739A
(es)
|
2010-12-16 |
2013-07-17 |
Roche Glycart Ag |
Terapia combinada de anticuerpo cd20 afucosilado con inhibidor de mdm2.
|
|
WO2012083181A1
(en)
|
2010-12-16 |
2012-06-21 |
Indiana University Research And Technology Corporation |
Alpha helix mimetics and methods for using
|
|
UY33808A
(es)
|
2010-12-17 |
2012-07-31 |
Syngenta Participations Ag |
Compuestos insecticidas
|
|
EP2474625B1
(en)
|
2011-01-05 |
2016-11-02 |
Daniela Kandioler |
Method for determining the p53 status of a tumour
|
|
EP2474624B1
(en)
|
2011-01-05 |
2016-08-17 |
Daniela Kandioler |
Response prediction in cancer treatment (p53 adapted cancer therapy)
|
|
CN102614491B
(zh)
*
|
2011-01-31 |
2014-04-16 |
上海天伟生物制药有限公司 |
一种含有棘白菌素类抗真菌剂米卡芬净的药用组合物及其制备方法和用途
|
|
JP5950587B2
(ja)
|
2011-02-28 |
2016-07-13 |
キヤノン株式会社 |
多孔質ガラスの製造方法および光学部材の製造方法
|
|
JP6239979B2
(ja)
|
2011-03-04 |
2017-11-29 |
ニューヨーク・ユニバーシティ |
Ｒａｓの調節因子としての水素結合代替大環状分子
|
|
CN103415530A
(zh)
|
2011-03-09 |
2013-11-27 |
Jitsubo株式会社 |
新型的含有非肽性交联结构的交联肽、以及该交联肽的合成方法和用于该方法的新型有机化合物
|
|
AU2012226890B2
(en)
|
2011-03-10 |
2016-10-06 |
Daiichi Sankyo Company, Limited |
Dispiropyrrolidine derivative
|
|
CA2834657A1
(en)
|
2011-04-29 |
2012-11-01 |
Kinemed, Inc. |
Chemical modification of apolipoprotein mimetic peptides for the production of therapeutic agents
|
|
WO2012173846A2
(en)
|
2011-06-06 |
2012-12-20 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
|
EP2721061A4
(en)
|
2011-06-17 |
2014-11-05 |
Harvard College |
VARIANT STABILIZED MAML-PEPTIDES AND USES THEREOF
|
|
WO2012174423A1
(en)
|
2011-06-17 |
2012-12-20 |
President And Fellows Of Harvard College |
Stabilized polypeptides as regulators of rab gtpase function
|
|
GB201110390D0
(en)
|
2011-06-20 |
2011-08-03 |
Medical Res Council |
Compounds for use in stabilising p53 mutants
|
|
US20120328692A1
(en)
|
2011-06-24 |
2012-12-27 |
University Of Maryland, Baltimore |
Potent d-peptide antagonists of mdm2 and mdmx for anticancer therapy
|
|
US20130123196A1
(en)
|
2011-08-31 |
2013-05-16 |
New York University |
Thioether-, ether-, and alkylamine-linked hydrogen bond surrogate peptidomimetics
|
|
WO2013036208A1
(en)
|
2011-09-09 |
2013-03-14 |
Agency For Science, Technology And Research |
P53 activating peptides
|
|
CN102488889B
(zh)
*
|
2011-09-26 |
2014-01-22 |
上海天伟生物制药有限公司 |
一种低杂质含量的卡泊芬净制剂及其制备方法和用途
|
|
MX352672B
(es)
|
2011-09-27 |
2017-12-04 |
Amgen Inc |
Compuestos heterocíclicos como inhibidores de mdm2 para el tratamiento del cáncer.
|
|
WO2013059530A2
(en)
|
2011-10-18 |
2013-04-25 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
|
AR088392A1
(es)
|
2011-10-18 |
2014-05-28 |
Aileron Therapeutics Inc |
Macrociclos peptidomimeticos
|
|
EP2771008A4
(en)
|
2011-10-28 |
2015-04-08 |
Merck Sharp & Dohme |
MACROCYCLES FOR INCREASING P53 ACTIVITY AND USES THEREOF
|
|
US9408885B2
(en)
|
2011-12-01 |
2016-08-09 |
Vib Vzw |
Combinations of therapeutic agents for treating melanoma
|
|
CA2761253A1
(en)
|
2011-12-07 |
2013-06-07 |
Vib Vzw |
Combinations of therapeutic agents for treating melanoma
|
|
HK1205454A1
(en)
|
2012-02-15 |
2015-12-18 |
Aileron Therapeutics, Inc. |
Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
|
|
CA2862038C
(en)
*
|
2012-02-15 |
2021-05-25 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
|
US9890429B2
(en)
|
2012-02-29 |
2018-02-13 |
Dana-Farber Cancer Institute, Inc. |
Compositions, kits, and methods for the identification, assessment, prevention, and therapy of cancer
|
|
EP2820041B1
(en)
|
2012-03-02 |
2017-06-14 |
Ludwig Institute For Cancer Research Ltd. |
Iaspp phosphorylation and metastatic potential
|
|
SG11201405578TA
(en)
*
|
2012-03-09 |
2014-11-27 |
Oncotherapy Science Inc |
Pharmaceutical composition containing peptide
|
|
US9216170B2
(en)
|
2012-03-19 |
2015-12-22 |
Hoffmann-La Roche Inc. |
Combination therapy for proliferative disorders
|
|
US9371568B2
(en)
|
2012-07-31 |
2016-06-21 |
Novartis Ag |
Markers associated with human double minute 2 inhibitors
|
|
ES2874525T3
(es)
|
2012-09-26 |
2021-11-05 |
Harvard College |
Péptidos grapados bloqueados con prolina y usos de los mismos
|
|
WO2014055564A1
(en)
|
2012-10-01 |
2014-04-10 |
President And Fellows Of Harvard College |
Stabilized polypeptide insulin receptor modulators
|
|
BR112015009470A2
(pt)
|
2012-11-01 |
2019-12-17 |
Aileron Therapeutics Inc |
aminoácidos dissubstituídos e seus métodos de preparação e uso
|
|
WO2014138429A2
(en)
|
2013-03-06 |
2014-09-12 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles and use thereof in regulating hif1alpha
|
|
KR20150131244A
(ko)
|
2013-03-13 |
2015-11-24 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
스테이플드 및 스티치드 폴리펩티드 및 그의 용도
|
|
WO2014144121A2
(en)
|
2013-03-15 |
2014-09-18 |
Life Technologies Corporation |
Classification and actionability indices for lung cancer
|
|
US9198910B2
(en)
|
2013-04-04 |
2015-12-01 |
The Translational Genomics Research Institute |
Methods for the treatment of cancer
|
|
CA2909683A1
(en)
|
2013-04-16 |
2014-10-23 |
Memorial Sloan-Kettering Cancer Center |
Companion diagnostic for cdk4 inhibitors
|
|
CA2915354A1
(en)
|
2013-06-14 |
2014-12-18 |
President And Fellows Of Harvard College |
Stabilized polypeptide insulin receptor modulators
|
|
BR112015031542A2
(pt)
|
2013-07-03 |
2017-07-25 |
Hoffmann La Roche |
métodos de previsão de reação de pacientes com câncer, método de tratamento de câncer, kit de previsão da reação ao tratamento e processos, métodos e usos inovadores
|
|
US9268662B2
(en)
|
2013-08-01 |
2016-02-23 |
Oracle International Corporation |
Method and system for a high availability framework
|
|
US20160022720A1
(en)
|
2013-08-02 |
2016-01-28 |
Children's Hospital Medical Center |
Compositions and methods for treating disease states associated with activated t cells and/or b cells
|
|
CN106103472A
(zh)
|
2013-10-01 |
2016-11-09 |
哈佛大学的校长及成员们 |
稳定化的多肽及其用途
|
|
US20160115556A1
(en)
|
2013-10-19 |
2016-04-28 |
Trovagene, Inc. |
Detecting mutations in disease over time
|
|
HRP20220718T1
(hr)
|
2013-11-11 |
2022-09-30 |
Amgen Inc. |
Kombinacijska terapija uključujući inhibitor mdm2 i jedan ili više dodatnih farmaceutski aktivnih sredstava za liječenje raka
|
|
PT3077004T
(pt)
|
2013-12-05 |
2020-04-16 |
Hoffmann La Roche |
Novo tratamento de combinação para a leucemia mieloide aguda (lma)
|
|
EP3086810A2
(en)
|
2013-12-23 |
2016-11-02 |
Novartis AG |
Pharmaceutical combinations
|
|
US20160333419A1
(en)
|
2014-01-14 |
2016-11-17 |
Daiichi Sankyo Company, Limited |
Gene signatures associated with sensitivity to mdm2 inhibitors
|
|
WO2015157508A1
(en)
|
2014-04-09 |
2015-10-15 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles with pth activity
|
|
US20170184604A1
(en)
|
2014-05-22 |
2017-06-29 |
The General Hospital Corporation |
Dd1alpha receptor and uses thereof in immune disorders
|
|
TW201613576A
(en)
|
2014-06-26 |
2016-04-16 |
Novartis Ag |
Intermittent dosing of MDM2 inhibitor
|
|
ES2771926T3
(es)
|
2014-09-13 |
2020-07-07 |
Novartis Ag |
Terapias de combinación
|
|
SG11201702175YA
(en)
|
2014-09-24 |
2017-04-27 |
Aileron Therapeutics Inc |
Peptidomimetic macrocycles and formulations thereof
|
|
WO2016049359A1
(en)
|
2014-09-24 |
2016-03-31 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles and uses thereof
|
|
JP2017532959A
(ja)
|
2014-10-09 |
2017-11-09 |
第一三共株式会社 |
Ｍｄｍ２阻害剤に対する感受性の遺伝子シグネチャーに基づく予測因子に関するアルゴリズム
|
|
EP3204776B1
(en)
|
2014-10-10 |
2019-09-04 |
F.Hoffmann-La Roche Ag |
Methods for personalizing patient cancer therapy with an mdm2 antagonist
|
|
US10302644B2
(en)
|
2014-11-04 |
2019-05-28 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for treating multiple myeloma
|
|
WO2016105503A1
(en)
|
2014-12-24 |
2016-06-30 |
Genentech, Inc. |
Therapeutic, diagnostic and prognostic methods for cancer of the bladder
|
|
US10253067B2
(en)
|
2015-03-20 |
2019-04-09 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles and uses thereof
|
|
US10059741B2
(en)
|
2015-07-01 |
2018-08-28 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
|
WO2017004591A2
(en)
|
2015-07-02 |
2017-01-05 |
Dana-Farber Cancer Institute, Inc. |
Stabilized anti-microbial peptides
|
|
WO2017023933A2
(en)
|
2015-08-03 |
2017-02-09 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
|
WO2017040990A1
(en)
|
2015-09-03 |
2017-03-09 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles and uses thereof
|
|
JP2018528217A
(ja)
|
2015-09-10 |
2018-09-27 |
エルロン・セラピューティクス・インコーポレイテッドＡｉｌｅｒｏｎ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． |
Ｍｃｌ−１のモジュレーターとしてのペプチド模倣大環状分子
|
|
WO2017205786A1
(en)
|
2016-05-27 |
2017-11-30 |
Aileron Therapeutics, Inc. |
Cell permeable peptidomimetic macrocycles
|
|
US20170360881A1
(en)
|
2016-06-17 |
2017-12-21 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles and uses thereof
|
|
WO2018165575A2
(en)
|
2017-03-09 |
2018-09-13 |
Aileron Therapeutics, Inc. |
Warhead-containing peptidomimetic macrocycles as modulators of bfl-1
|